|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, less allowances ($110 and $76, respectively) | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Noncurrent assets of discontinued operations | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| CURRENT LIABILITIES: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Current operating lease liabilities | ||||||||||||||||||||
| Current portion of promissory notes payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred taxes, net | ||||||||||||||||||||
| Noncurrent operating lease liabilities | ||||||||||||||||||||
| Promissory notes payable | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Noncurrent liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY: | ||||||||||||||||||||
| Common stock, no-par value; authorized - 200,000 shares; 114,900 shares issued and 109,870 shares outstanding at June 30, 2026 and 114,900 shares issued and 109,413 shares outstanding at September 30, 2025 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost - 6,128 shares at March 31, 2024 and 3,411 shares at September 30, 2023 | ||||||||||||||||||||
| Treasury stock; at cost - 5,030 shares at June 30, 2026 and 5,487 shares at September 30, 2025 | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
Loading...